The strong beat and reaffirmed guidance support a positive near-term outlook. Monitor the upcoming Form 10 filing and separation milestones for further catalyst. The stock may price in the beat quickly, so consider taking profits on a pop if guidance is not raised.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 6 $81.58entry
- T+1 · 6mo ago −3.10%α −2.77% · $79.05
- T+5 · 6mo ago +1.23%α +0.10% · $82.59
- T+20 · 6mo ago −4.64%α −7.42% · $77.80
- T+60 · 4mo ago +9.51%α +8.44% · $89.34
Price Chart
How similar events traded
Executive Summary
Corteva reported strong Q1 2026 results with net sales up 11% YoY to $4.905B and operating EPS of $1.50, significantly beating consensus of $1.18. The company reaffirmed its full-year 2026 guidance, expecting operating EBITDA of $4.0-$4.2B and operating EPS of $3.45-$3.70. Growth was driven by volume gains in both Seed and Crop Protection segments, with organic sales up 7% overall.
Key Financial Metrics
Key Facts
- Net sales $4.905B (+11% YoY, +7% organic), beating $4.64B consensus
- GAAP diluted EPS from continuing ops $1.07 vs $0.97 YoY
- Operating EPS (non-GAAP) $1.50 vs $1.13 YoY, exceeding $1.18 consensus by 27%
- Operating EBITDA $1.438B (+21% YoY)
- Seed net sales $3.023B (+12%), Crop Protection $1.882B (+10%)
- Reaffirmed FY2026 guidance: Op. EBITDA $4.0-$4.2B, Op. EPS $3.45-$3.70
- $500M share repurchase planned in H1 2026
- Company on track for planned separation in H2 2026
Financial Impact
Revenue beat consensus by $265M; operating EPS beat by $0.32 per share
Risk Factors
- Q1 revenue benefited from seasonal timing shifts; H2 may not sustain same momentum
- Litigation settlement ($85M) and restructuring charges ($92M) impacted GAAP results
- Currency headwinds and competitive pricing in Latin America could pressure margins
- Execution risk from planned separation into two companies
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001755672-26-000008 |
| Document: ctva-20260505.htm | 0001755672-26-000008 |
| Document: a1q_2026xearningsxnewsxr.htm | 0001755672-26-000008 |
| Document: 0001755672-26-000008-index-headers.html | 0001755672-26-000008 |
| Document: 0001755672-26-000008-index.html | 0001755672-26-000008 |
| Document: 0001755672-26-000008.txt | 0001755672-26-000008 |
| 8-K Data (Synthetic) | 0001755672-26-000008 |
Track record
28 reports on CTVA
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $9.43 to $9.04 Now $9.04 −4.14% ▼ −4.14% −2.22% vs SPY
- Nov 12, 20264d ago 8-K Bearish 6/10 Entry $9.19 to $9.43 Now $9.04 +1.63% ▼ −2.61% −2.97% vs SPY
- Nov 10, 20266d ago NT 10-Q Neutral 4/10 Entry $12.14 to $9.19 Now $9.04 −25.54% ▼ −24.30% −23.95% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $11.90 to $12.11 Now $9.04 −24.03% ▲ +1.76% −0.60% vs SPY
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $12.04 to $11.90 Now $9.04 −24.92% ▼ −1.16% −1.48% vs SPY
- Nov 4, 202612d ago SC 13G/A Neutral 3/10 Entry $12.04 to $11.90 Now $9.04 −24.92% ▼ −1.16% −1.48% vs SPY
- Oct 28, 202619d ago Institutional Cluster Mixed 3/10 Entry $11.33 to $11.47 Now $9.04 −20.21% ▲ +1.24% +1.62% vs SPY
- Oct 23, 202624d ago Press Release Neutral 2/10 Entry $12.45 to $11.95 Now $9.04 −27.39% ▼ −4.02% −4.73% vs SPY
- Oct 13, 20264w ago 8-K Bearish 6/10 Entry $13.36 to $13.40 Now $9.04 +32.34% ▼ −0.30% −1.38% vs SPY
- Oct 5, 20265w ago 3 Neutral 2/10 Entry $13.91 to $14.45 Now $9.04 −35.01% ▲ +3.88% +4.12% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers